5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages
Citations Over TimeTop 10% of 2017 papers
Abstract
5-Hydroxymethylcytosine (5hmC) is an important mammalian DNA epigenetic modification that has been linked to gene regulation and cancer pathogenesis. Here we explored the diagnostic potential of 5hmC in circulating cell-free DNA (cfDNA) using a sensitive chemical labeling-based low-input shotgun sequencing approach. We sequenced cell-free 5hmC from 49 patients of seven different cancer types and found distinct features that could be used to predict cancer types and stages with high accuracy. Specifically, we discovered that lung cancer leads to a progressive global loss of 5hmC in cfDNA, whereas hepatocellular carcinoma and pancreatic cancer lead to disease-specific changes in the cell-free hydroxymethylome. Our proof-of-principle results suggest that cell-free 5hmC signatures may potentially be used not only to identify cancer types but also to track tumor stage in some cancers.
Related Papers
- → Uncovering the role of 5-hydroxymethylcytosine in the epigenome(2011)762 cited
- → Tet family proteins and 5-hydroxymethylcytosine in development and disease(2012)371 cited
- → The role of 5-hydroxymethylcytosine in development, aging and age-related diseases(2017)89 cited
- → The Elusive Role of 5′-Hydroxymethylcytosine(2016)35 cited
- → Epigenomic analysis of 5-hydroxymethylcytosine (5hmC) reveals novel DNA methylation markers for lung cancers(2020)31 cited